Renal Tumors in 26-Week Tg.Rash2 Mice Carcinogenicity Studies

Madhav G Paranjpe1, Jessica L Belich2, Marie E McKeon2

  • 1BioReliance by SAFC, Rockville, Maryland, USA madhav.paranjpe@bioreliance.com.

Toxicologic Pathology
|February 18, 2016
PubMed

Insights

Spontaneous renal tubular adenomas and carcinoma were observed in Tg.rasH2 mice during carcinogenicity studies. These novel findings in mouse models suggest random tumor development unrelated to study compounds.

Area of Science:

  • Toxicology
  • Oncology
  • Genetics

Background:

  • Renal tubular tumors, specifically adenomas and carcinomas, are uncommon findings in Tg.rasH2 mouse carcinogenicity studies.
  • Previous reports from our facility and published literature have not documented these specific renal tumors in this mouse model.

Purpose of the Study:

  • To investigate the occurrence and potential origins of newly observed renal tubular adenomas and carcinomas in Tg.rasH2 mice.
  • To determine if the renal tumors were linked to genetic factors, environmental contaminants, or study-related treatments.

Main Methods:

  • Tg.rasH2 mice from carcinogenicity studies conducted in 2014 were examined for renal tumors.
  • Parental lineage and animal handling procedures were reviewed to trace the origin of the tumors.
  • Morphological similarities to known rat renal tumor variants were assessed.

Main Results:

  • Renal tubular adenomas and a carcinoma were identified in 26-week-old Tg.rasH2 mice.
  • Tumor development was not linked to parental lineage, animal facility barriers, vehicle, or test articles.
  • The observed renal tumors exhibited morphological similarities to the amphophilic-vacuolar (AV) phenotypic variant found in rats.

Conclusions:

  • The development of renal tumors in Tg.rasH2 mice appears to be a spontaneous and random event.
  • Further investigation into the precise mechanism of tumorigenesis is warranted.
  • These findings highlight the importance of characterizing spontaneous lesions in genetically modified mouse models for carcinogenicity studies.